National CineMedia (NCMI) had the highest return between April 1, 2023 and May 5, 2023 by a small-cap US stock, returning 127.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
National CineMedia (NCMI) | 4/1/2023 - 5/5/2023 | 127.59% |
Eyepoint Pharmaceuticals (EYPT) | 4/1/2023 - 5/5/2023 | 123.21% |
Pulse Biosciences (PLSE) | 4/1/2023 - 5/5/2023 | 119.68% |
Akebia Ther (AKBA) | 4/1/2023 - 5/5/2023 | 89.83% |
Olema Pharmaceuticals (OLMA) | 4/1/2023 - 5/5/2023 | 89.74% |
X4 Pharmaceuticals (XFOR) | 4/1/2023 - 5/5/2023 | 88.89% |
Aquestive Therapeutics (AQST) | 4/1/2023 - 5/5/2023 | 77.39% |
Sana Biotechnology (SANA) | 4/1/2023 - 5/5/2023 | 77.02% |
Phathom Pharmaceuticals (PHAT) | 4/1/2023 - 5/5/2023 | 75.68% |
Oculis Holding AG Ordinary shares (OCS) | 4/1/2023 - 5/5/2023 | 70.76% |
MiMedx (MDXG) | 4/1/2023 - 5/5/2023 | 68.82% |
American Coastal Insurance (ACIC) | 4/1/2023 - 5/5/2023 | 65.94% |
Prothena (PRTA) | 4/1/2023 - 5/5/2023 | 62.85% |
P3 Health Partners (PIII) | 4/1/2023 - 5/5/2023 | 59.65% |
Opus Genetics (IRD) | 4/1/2023 - 5/5/2023 | 59.28% |
Collective Mining (CNL) | 4/1/2023 - 5/5/2023 | 58.13% |
Cabaletta Bio (CABA) | 4/1/2023 - 5/5/2023 | 53.79% |
Bit Digital (BTBT) | 4/1/2023 - 5/5/2023 | 53.25% |
Atomera (ATOM) | 4/1/2023 - 5/5/2023 | 52.76% |
Immix Biopharma (IMMX) | 4/1/2023 - 5/5/2023 | 46.45% |
Xeris Pharmaceuticals (XERS) | 4/1/2023 - 5/5/2023 | 46.34% |
Immatics (IMTX) | 4/1/2023 - 5/5/2023 | 45.32% |
Lexicon Pharmaceuticals (LXRX) | 4/1/2023 - 5/5/2023 | 44.81% |
Ovid Therapeutics (OVID) | 4/1/2023 - 5/5/2023 | 42.35% |
Relmada Therapeutics (RLMD) | 4/1/2023 - 5/5/2023 | 41.23% |
Small-cap stocks are treated as having a market cap between $300M and $2B.